Robert Skala
Family Medicine · Eagle River, AKNPI 1598825663
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,800 of the $38,074 with a category attached, or 73.0%. AstraZeneca accounts for 70.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $21,093 and has fallen 98.6% since, to $287 in 2025. Among family medicine clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $187.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$27K
- Boehringer Ingelheim$6K
- Lilly USA, LLC$3K
- AbbVie$529
- Novo Nordisk$421
- Tandem Diabetes Care, Inc.$366
- plus $2K from 15 others
What the payments were for
- Consulting fees$2,2506%
- Speaking & faculty fees$27,80073%
- Travel & lodging$2,7417%
- Food & beverage$5,28314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 83 | $26,675 |
| Boehringer Ingelheim | 18 | $5,670 |
| Lilly USA, LLC | 20 | $2,811 |
| AbbVie(2 entities) | 19 | $529 |
| Novo Nordisk | 10 | $421 |
| Tandem Diabetes Care, Inc. | 4 | $366 |
| Novartis | 6 | $286 |
| Merck | 3 | $202 |
| Sanofi-aventis U.S. LLC | 18 | $187 |
| Bayer | 2 | $151 |
| Abbott | 4 | $142 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $104 |
| Amarin Pharma, Inc. | 2 | $93 |
| Amgen | 2 | $85 |
| Dexcom, Inc. | 2 | $67 |
| Medtronic | 1 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Pfizer | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,074 in reported general payments places this provider in the 95th percentile of 334 family medicine providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 111 | $156,480 |
| Humira PenAdalimumab | 11 | $104,237 |
| JardianceEmpagliflozin | 56 | $87,643 |
| FarxigaDapagliflozin Propanediol | 39 | $58,615 |
| OzempicSemaglutide | 32 | $48,610 |
| EliquisApixaban | 27 | $34,513 |
| RybelsusSemaglutide | 14 | $27,645 |
| JanuviaSitagliptin Phosphate | 17 | $27,334 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $19,139 |
| GlyxambiEmpagliflozin/Linagliptin | 13 | $16,708 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $16,196 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $15,603 |
| KerendiaFinerenone | 12 | $14,664 |
| Novolog FlexpenInsulin Aspart | 25 | $9,646 |
| Carvedilol ErCarvedilol Phosphate | 15 | $9,424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $2,811 | $156,480111 claims |
| Boehringer IngelheimJardiance, Glyxambi, Combivent Respimat | $5,670 | $120,54688 claims |
| Novo NordiskOzempic, Rybelsus | $421 | $76,25546 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $26,675 | $74,21858 claims |
| PfizerEliquis | $23 | $34,51327 claims |
| MerckJanuvia | $202 | $27,33417 claims |
| BayerKerendia | $151 | $14,66412 claims |
| AbbVieSynthroid | $529 | $1,56119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 334 family medicine providers in Alaska.
Other family medicine in Eagle River
- Heather JonesEagle River$7K
- Martin GlavesEagle River$5K
- John CullenValdez$32K
- Mary FolandAnchorage$15K
- Ilona FarrAnchorage$14K
- Eric MiknichAnchorage$13K
- Ray KelleyWasilla$9K
- Russell PierceFairbanks$7K
- Frank GreathouseWasilla$7K
- Allison KelliherAnchorage$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.